• 1
    Kulseng-Hanssen S, Dyrkorn OA, Sandvik L. Result from a national incontinence registry: TVT is a better surgical procedure for treating stress incontinence, compared to TVT-O and TOT. Neurourol Urodyn 2009; 28: 5835.
  • 2
    Scheiner D, Betschart C, Werder H, Fink D, Perucchini D. Retropubic TVT Vs transobturator outside-in TOT and inside-out TVT-O - One year results from our prospective randomized study. Neurourol Urodyn 2009; 28: 5856.
  • 3
    Lee K, Lee L, Seo JT, Na YG, Seo JH, Lee JG, Choo M, Kim JC, Yoon JM, Kim DY, Yoo ES, Lee JZ. A prospective multicenter randomized study of 'U' and 'H' approach of TVT-Secur procedure for the treatment of female stress urinary incontinence: one-year follow-up. Neurourol Urodyn 2009; 28: 5878.
  • 4
    Barber M, Brubaker L, Nygaard I, Wheeler T, Schaffer J, Chen Z, Spino C. Defining “success” after surgery for pelvic organ prolapse. Neurourol Urodyn 2009; 28: 5901.
  • 5
    de Boer T, Vierhout M. Do OAB symptoms improve after surgery for POP? Neurourol Urodyn 2009; 28: 5912.
  • 6
    Ismail S. Complications of mesh kits for pelvic organ prolapse: a review of Manufacturer And User facility Device Experience (MAUDE) databases. Neurourol Urodyn 2009; 28: 5934.
  • 7
    Weincke MO, Sakse AE, Olsen T, Troelstrup A, Westh B. A randomized controlled trial on prophylactic antibiotics and pelvic organ prolapse surgery. Neurourol Urodyn 2009; 28: 5945.
  • 8
    Kong W, Lin D, Kinley B, Kerns J, Damaser M. Urethral neuromuscular injury following simulated childbirth injury in a rat model. Neurourol Urodyn 2009; 28: 5978.
  • 9
    Peters K, Killinger K, Boguslawski B. Pudendal neurostimulation is a viable alternative to sacral nerve stimulation for voiding dysfunction. Neurourol Urodyn 2009; 28: 599600.
  • 10
    Ghazwani Y, Elkelini M, Hassouna M. Association between stimulation parameters at the time of implantation of sacral nerve stimulator and explantation after successful implantation. Neurourol Urodyn 2009; 28: 6001.
  • 11
    Powell C, Takacs E, Kreder K. Patient age predicts success in patients undergoing sacral neuromodulation for voiding dysfunction. Neurourol Urodyn 2009; 28: 602.
  • 12
    Andretta E, Ostardo E, Simeone C, Signorello D, Pastorello M, Campo C, Limido L, Bastianello P. Results of sacral nerve modulation for the treatment of bladder dysfunctions in multiple sclerosis patients. Neurourol Urodyn 2009; 28: 6034.
  • 13
    Honjo H, Ukimura O, Kawauchi A, Kitakoji H, Nakao M, Miki T. Impact of convenience void in bladder diary which involves self-reported urinary perception to assess bladder sensitivity. Neurourol Urodyn 2009; 28: 6045.
  • 14
    Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G, Bard R, Valiquette L, Baverstock R, Radomski S, Carr L. Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence - A randomized double-blind trial. Neurourol Urodyn 2009; 28: 6089.
  • 15
    Grahn S, Varma M, Schembri M, Thom D, Van Den Eeden S, Brown J. Fecal incontinence: a population based study of severity and quality of life. Neurourol Urodyn 2009; 28: 622.
  • 16
    Wilde M, Brasch J, Getliffe K, McMahon J, Anson E, Tu X. A new catheter-related quality of life instrument for long-term urinary catheter users. Neurourol Urodyn 2009; 28: 6267.
  • 17
    Basra R, Khullar V, Kelleher C. Does long-term treatment of overactive bladder result in clinically meaningful improvement in health related quality of life in real world clinical practice? Neurourol Urodyn 2009; 28: 6345.
  • 18
    den Hollander P, Snoek G, Martens F, Koldewijn E, van Kerrebroeck P, Heesakkers J. The Brindley bladder stimulator improves quality of life and clinical outcomes in spinal cord injured patients as compared to a matched control group. Neurourol Urodyn 2009; 28: 63940.
  • 19
    DuBeau C, Fitzgerald MP, Johnson H, Kraus S, Lemack G, Mallett V, Stoddard A, Tennstedt S, Zyczynski H. Expectations of urge incontinence treatment and their relationship to outcomes. Neurourol Urodyn 2009; 28: 6423.
  • 20
    Basra R, Khullar V, Kelleher C. Long-term use of antimuscarinic medication in the real world: results of a community-based prospective study of patients with overactive bladder. Neurourol Urodyn 2009; 28: 6445.
  • 21
    Svihra J, Luptak J, Kliment J, Vasil J, Brenisin P, Kovacik V, Macko L, Skladany L. Validation of the Urgencymetry 1.0 - Quantification of the urinary urgency in females. Neurourol Urodyn 2009; 28: 6467.
  • 22
    Platte R, Minassian V, Wood C, Parekh M, Poplawsky D. Are urinary tract infections and urinary incontinence in women associated with each other? Neurourol Urodyn 2009; 28: 6612.
  • 23
    Lovegrove Jones R, Peng Q, Humphrey V, Stokes M, Payne C, Constantinou CE. Effect of “The Knack” on the pelvic floor: evaluated by 2D real time ultrasound and image processing methods. Neurourol Urodyn 2009; 28: 6623.
  • 24
    Li X, Kruger J, Nash M, Nielsen P. Modelling fetal head motion and its mechanical interaction with the pelvic floor during childbirth. Neurourol Urodyn 2009; 28: 6723.
  • 25
    Raizada V, Bhargava V, Jung S, Karsten A, Pretorius D, Krysal P, Mittal R. Dynamic assessment of the vaginal high pressure zone using high definition manometry, 3-dimensional ultrasound & magnetic resonance imaging of the pelvic floor. Neurourol Urodyn 2009; 28: 6735.
  • 26
    Kruger J, Heap S, Murphy B, Dietz HP. Evidence for the non Euclidean nature of the plane of minimal dimensions. Neurourol Urodyn 2009; 28: 6756.
  • 27
    Grill R, Baca V, Horak Z, Otcenasek M, Smrzova T, Kachlik D, Dzupa V. Real 3D biomechanical models of pelvis and pelvic floor as the way to improve knowledge about incontinence. Neurourol Urodyn 2009; 28: 67980.
  • 28
    Goode P, Burgio K, Johnson T, Roth D, Clay O, Burkhardt J, Lloyd K. Behavioural therapy with or without biofeedback and pelvic floor electrical stimulation for persistent post-prostatectomy incontinence - a randomized controlled trial. Neurourol Urodyn 2009; 28: 6812.
  • 29
    Zafirakis H, Alba F, Westney OL. Preoperative pad weight and pad number as a predictor of failure of single cuff artificial urinary sphincter. Neurourol Urodyn 2009; 28: 6834.
  • 30
    Waltregny D, Leruth J, de Leval J. The inside-out transobturator sling for the surgical treatment of post-radical prostatectomy urinary incontinence: interim results of a prospective, observational study after a 1-year minimum follow-up. Neurourol Urodyn 2009; 28: 6878.
  • 31
    Hind A, Pini G, Viola D, Martino F, Rossi R, Leoni S. Urodynamic and clinical results of an adjustable sling for male urinary incontinence - 32 months follow up - Argus is effective also in severe cases. Neurourol Urodyn 2009; 28: 689.
  • 32
    Schlomer B, Valadez C, Dugi D, Morey A. Optimizing Advance sling outcomes via intraoperative urethroscopic confirmation of sling positioning. Neurourol Urodyn 2009; 28: 690.
  • 33
    Gregori A, Romano AL, Pietrantuono F, Salvaggio A, Granata A, Incarbone P, Scieri F, Gaboardi F. Transrectal ultrasound-guided implantation of the ProACT system in patients with post-radical prostatectomy stress urinary incontinence: clinical results after a mean follow up of 2 years. Neurourol Urodyn 2009; 28: 6934.
  • 34
    Broqueres-You D, Behr-Roussel D, Oger S, Compagnie S, Caisey S, Denys P, Chartier-Kastler E, Giuliano F. Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats. Neurourol Urodyn 2009; 28: 6956.
  • 35
    Everaerts W, Leten C, Appendino G, Voets T, Nilius B, De Ridder D. APP441-1, a novel TRPV4 agonist is able to induce bladder overactivity in rats and mice. Neurourol Urodyn 2009; 28: 7012.
  • 36
    Mochizuki T, Araki I, Yoshiyama M, Takeda M. Functional role of the TRPV4 cation channel in stretch-evoked Ca2+ influx and ATP release in mouse urothelial primary cultures. Neurourol Urodyn 2009; 28: 7067.
  • 37
    Everaerts W, Owsianik G, Vriens J, Talavera K, Van Haute C, Nilius B, De Ridder D. Functional characterisation of TRP channels in mouse urothelium: a major role for TRPV4. Neurourol Urodyn 2009; 28: 70910.
  • 38
    Kay G, Staskin D, MacDiarmid S, McIlwain M, Dahl N. Are the effects of oxybutynin on cognition dependent upon the route of administration - topical or oral? A double-blind placebo controlled study employing sensitive cognitive and psychomotor testing. Neurourol Urodyn 2009; 28: 7112.
  • 39
    Sherburn M, Bo K, Galea M. Evaluation of outcome measures for stress urinary incontinence in older women. Neurourol Urodyn 2009; 28: 7156.
  • 40
    Clemens JQ. The role of industry funding in randomized controlled trials of antimuscarinic medications for overactive bladder. Neurourol Urodyn 2009; 28: 727.
  • 41
    Nguyen A, Aschkenazi S, Gamble T, Vu M, Secco A, Kuo R, Du H, Botros S, Sand P, Goldberg R. Environmental factors versus genetics in women wit fecal incontinence: a classical twin study of identical and non-identical twins. Neurourol Urodyn 2009; 28: 728.
  • 42
    Jahanlu D, Hunskaar S. Prevalence of urinary incontinence during 10 years in a prospective cohort of middle aged women. Neurourol Urodyn 2009; 28: 72930.
  • 43
    Wesnes SL, Hunskaar S, Bo K, Rortveit G. How does weight gain during pregnancy affect risk of urinary incontinence? Neurourol Urodyn 2009; 28: 7312.
  • 44
    Wagg A, Lowe D, Peel P, Potter J. Does good organisational structure lead to quality care provision for older people with incontinence? Neurourol Urodyn 2009; 28: 7367.
  • 45
    Burmeister D, AbouShwareb T, Andersson K, Christ G. Establishing a rodent model for characterization of natural in vivo bladder regeneration. Neurourol Urodyn 2009; 28: 73940.
  • 46
    Janssen DAW, Jansen KCFJ, Schalken JA, Heesakkers J. TRPV4 as stretch-receptor; co-localization between TRPV4 and adherence junctions in urothelium of human kidney, ureter & urinary bladder. Neurourol Urodyn 2009; 28: 7478.
  • 47
    Janssen DAW, Jansen KCFJ, Schalken JA, Heesakkers J. TRPV4 as a mechanoreceptor in the human bladder; a co-localization between TRPV4 and adherence junctions the urothelium. Neurourol Urodyn 2009; 28: 74950.
  • 48
    Shiraiwa M, Shishido K, Nanri M, Kiniwa M, Yamaguchi O. How is the bladder behaviour influenced by the osmolarity of urine? Neurourol Urodyn 2009; 28: 7556.
  • 49
    Aoki Y, Kusukawa N, Maekawa M, Matsuta Y, Tanase K, Ito H, Oyama N, Miwa Y, Akino H, Yokoyama O. Relationship between nocturia and metabolic syndrome. Neurourol Urodyn 2009; 28: 761.
  • 50
    van Doorn B, Blanker M, Bosch R. The epidemiology of nocturnal polyuria (incidence and prevalence): a longitudinal community based study in men between 50 and 78 years of age. Neurourol Urodyn 2009; 28: 7656.
  • 51
    Khan S, Khasriya R, Bishara S, Mahmood W, Chandhyoke N, Mohenden M, Malone-Lee J. Preservation of urinary white cells to enable adoption of microscopy of unspun urine for pyuria into ordinary clinical assessment protocols of lower urinary tract symptoms. Neurourol Urodyn 2009; 28: 7746.
  • 52
    Lunawat R, Khasriya R, Falzon M, Balachandran L, Malone-Lee J. Spun urinary sediments and giemsa stain reveal a chronic inflammatory infiltrate in patients with symptoms of OAB. Neurourol Urodyn 2009; 28: 7767.
  • 53
    Khan S, Khasriya R, Badiani R, Bishara S, Malone-Lee J. Enhancing the detection of pyuria in fresh urine from patients with overactive bladder by use of the Sternheimer-Malbin stain. Neurourol Urodyn 2009; 28: 7778.
  • 54
    Khasriya R, Khan S, Ismail S, Ready D, Pratten J, Wilson M, Kelsey M, Malone-Lee J. Bacterial urinary tract infection in patients with OAB symptoms and negative midstream urine cultures exposed through culture of the urinary spun sediment. Neurourol Urodyn 2009; 28: 77980.
  • 55
    Lopez M, Snyder J. Can an air-filled intravesical balloon in-vivo attenuate pressure and raise the abdominal pressure at which stress urinary incontinence related leakage occurs? Neurourol Urodyn 2009; 28: 7813.
  • 56
    Haylen B, Freeman R, De Ridder D, Swift S, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK. An International Urogynecological Association (IUGA) - International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2009; 28: 7878.
  • 57
    Bodner B, Elenskaia K, Doerfler D, Umek W, Lami T, Haeusler G, Hanzai E. Surgical management of urethral diverticula in women: a systematic review. Neurourol Urodyn 2009; 28: 7912.
  • 58
    Gakis G, vanKoeveringe G, Raina S, Lorenz S, Rahnama'i M, Ninkovic M, Stenzi A, Sievert K. Latissimus dorsi detrusor myoplasty in patients with acontractile bladder - long term results of a multicenter study. Neurourol Urodyn 2009; 28: 7945.
  • 59
    Groen J, Blok B, Bosch R. Five-year follow-up of sacral nerve neuromodulation in 60 women with idiopathic refractory urge incontinence. Neurourol Urodyn 2009; 28: 7956.
  • 60
    Kuo H, Liu H, Chancellor M. Urinary Nerve Growth Factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence. Neurourol Urodyn 2009; 28: 805.
  • 61
    Ikeda Y, Birder L, DeGroat W, Kanai A. Interstitial Cell P2Y6-receptors modulate detrusor overactivity following spinal cord transection. Neurourol Urodyn 2009; 28: 8067.
  • 62
    Richter HE. A randomized trial of pessary vs. behavioural therapy vs. combined therapy for treatment of stress urinary incontinence. Neurourol Urodyn 2009; 28: 8167.
  • 63
    Elliott V, Dumoulin C, Martin C, Morin M, Lemieux M, Bourbonnais D. Physical therapy for persistent postpartum stress urinary incontinence: a seven year follow-up study. Neurourol Urodyn 2009; 28: 8201.
  • 64
    Cox M, Klutke J, Klutke C. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner's ulcer subtype interstitial cystitis. Neurourol Urodyn 2009; 28: 8268.
  • 65
    Price N, Carver J, Jackson S, Mardon H. Investigation of the function of integrin-mediated bacterial adherence proteins and their receptors in women with recurrent bacterial cystitis and interstitial cystitis. Neurourol Urodyn 2009; 28: 82930.
  • 66
    Gillatt D. Painful bladder and urinary tract pathology associated with long term ketamine use. Neurourol Urodyn 2009; 28: 8323.
  • 67
    Moore K, Hirst G, Emery S, Turner A, Lucas M. A double blind placebo controlled, randomised, cross over study of trigone specific injections of botulinum toxin B for treating patients with idiopathic detrusor overactivity refractory to other conservative treatments. Neurourol Urodyn 2009; 28: 8334.
  • 68
    Rudy D, Hanno P, Caramelli K, Thomas H, Hoel G. Quality of life in a randomized, double-blind, placebo-controlled study of oxybutynin chloride topical gel treatment of patients with overactive bladder. Neurourol Urodyn 2009; 28: 8346.
  • 69
    Cheng Y, Allan W, Walsh C, Mansfield KJ, Burcher E, Moore KH. ATP release during cystometry in women with detrusor overactivity and painful bladder syndrome: contribution to “urgency”? Neurourol Urodyn 2009; 28: 8389.
  • 70
    Kavia R, DasGupta R, Critchley H, Fowler C, Griffiths D. Abnormal brain responses to bladder filling in young women with urinary retention and effect of sacral neuromodulation. Neurourol Urodyn 2009; 28: 840.
  • 71
    Tadic S, Griffiths D, Schaefer W, Cheng C, Resnick N. Brain activity measured by functional magnetic resonance imaging (fMRI) is related to patient reports and clinical severity of urge urinary incontinence. Neurourol Urodyn 2009; 28: 8412.
  • 72
    Robert M, Birch C, Cenailo D, Murphy M, Carlson K, Baverstock R, Mainprize T, Ross S. Patient expectations, subjective improvement and objective cure: is there a difference between the transobturator tape and the tension free vaginal tape procedure? Neurourol Urodyn 2009; 28: 846.
  • 73
    Johnson E, Latini J. The impact of urethroplasty on voiding symptoms and sexual function. Neurourol Urodyn 2009; 28: 847.
  • 74
    Chung DE, Purohit R, Girshman J, Blaivas JG. Urethral diverticulae in women: discrepancies between MRI and surgical findings. Neurourol Urodyn 2009; 28: 8489.
  • 75
    Zhang Y, Timm G, Sweet R, Metzger G, Burke D, Erdman A. Computer model based dynamic urethrovaginal support assessment for female SUI. Neurourol Urodyn 2009; 28: 84950.
  • 76
    Pipiris A, Shek KL, Dietz HP. Urethral mobility and its relationship with urodynamic diagnosis. Neurourol Urodyn 2009; 28: 8512.
  • 77
    Haylen B, Lee J, Zhou J, Law M. Urine flow rates in women with symptoms of pelvic floor dysfunction. Neurourol Urodyn 2009; 28: 8578.
  • 78
    Aizawa N, Igawa Y, Wyndaele JJ. Effects of CL316,243, a beta3-adrenoceptor agonist, and prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn 2009; 28: 8634.
  • 79
    Moro C, Milligan C, Leeds C, Chess-Williams R. Spontaneous contractile activity of the urothelium is increased by muscarinic and purinergic receptor stimulation. Neurourol Urodyn 2009; 28: 8678.
  • 80
    Otsuka A, Matsumoto R, Shinbo H, Imanishi T, Kurita Y, Ozono S. Distribution of B-adrenoceptor subtypes in suburothelial interstitial cells of the human urinary bladder. Neurourol Urodyn 2009; 28: 8712.
  • 81
    Peters K, MacDiarmid S, Woolridge L, Leong FC, Shobeiri SA, Rovner E, Siegel S, Tate S, Faegins B. 6 and 12 month results from OrBIT trial comparing percutaneous tibial nerve stimulation (PTNS) vs. extended-release tolterodine. Neurourol Urodyn 2009; 28: 8812.
  • 82
    Thornton M, Collie M, McKinlay A, Bartolo D. Sacral nerve stimulation in Scotland. Neurourol Urodyn 2009; 28: 8834.
  • 83
    Zutshi M, Salcedo L, Penn M, Mayorga M, Hull T, Damaser M. Mesenchymal stem cells improve functional outcome after anal sphincter injury in a rat model. Neurourol Urodyn 2009; 28: 8845.
  • 84
    Svabik K, Martan A, Masata J, El Haddad R. Ultrasound assessment of the vaginal mesh shrinking in patient with anterior vaginal wall repair. Neurourol Urodyn 2009; 28: 88990.
  • 85
    Dyer K, Nguyen J, Lukacz E, Simsiman A, Luber K, Menefee S. The Optimal Anterior Repair Study (OARS): a triple arm randomized double blind clinical trial of standard colporrhaphy, porcine dermis or polypropylene mesh augmented anterior vaginal wall repair. Neurourol Urodyn 2009; 28: 8945.
  • 86
    Fritel X, Khoshnood B, Fauconnier A. Four years after first delivery, do urinary incontinence and anal incontinence share the same obstetrical risk factors? Neurourol Urodyn 2009; 28: 9023.
  • 87
    Crawford B, Zanjani E, Thain D, Stanford E, Van Andel R, Pixley J, Milsap L, Keller P. Ovine model of obstetric fistula. Neurourol Urodyn 2009; 28: 9056.
  • 88
    Ogawa T, Seki S, Imamura T, Igawa Y, Nishizawa O, Homma T, Akahane S, Homma Y. CXCR3 and related chemokines as possible biomarkers for ulcerative interstitial cystitis. Neurourol Urodyn 2009; 28: 9089.
  • 89
    Makino T, Kawashima H, Konishi H, Tanaka T, Nakatani T, Kiyama H. Elevated urinary levels of hepatocarcinoma-intestine-pancreas/pancratitis-associated protein (HIP/PAP) in patients with painful bladder syndromes/interstitial cystitis (PBS/IC). Neurourol Urodyn 2009; 28: 910.
  • 90
    Zabbarova I, Birder L, Roppolo J, DeGroat W, Kanai A. Bladder-colon cross-sensitization induced bladder overactivity. Neurourol Urodyn 2009; 28: 9145.
  • 91
    Dzung V, Haylen B, Kelly T, Annabelle F. Anatomy of the uterosacral ligament. Neurourol Urodyn 2009; 28: 917.
  • 92
    Bader G. Perineal approach to vascular anatomy during transobturator cystocele repair. Neurourol Urodyn 2009; 28: 91920.
  • 93
    van Doorn B, Blanker M, Bosch R. The incidence and prevalence of nocturia (increased nocturnal voiding frequency): results from a community based cohort study in older men. Neurourol Urodyn 2009; 28: 9289.